Published in Cancer on August 15, 1998
Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study. Am J Hematol (2009) 2.84
Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv (2010) 1.78
Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer (2005) 1.76
Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med (2002) 1.74
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol (2011) 1.62
Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial. J Natl Cancer Inst (2010) 1.59
Complementary medicine: implications for informed consent in general practice. Br J Gen Pract (2004) 1.50
Post-traumatic stress disorder: a challenge for primary care--misunderstood and incognito. Br J Gen Pract (2004) 1.46
Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria. BMC Complement Altern Med (2007) 1.45
Complementary evidence? J R Soc Med (2003) 1.39
Dangerous nutrition? Calcium, vitamin D, and shark cartilage nutritional supplements and cancer-related hypercalcemia. Support Care Cancer (2003) 1.37
Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer (2004) 1.36
Use of complementary and alternative medicines for children with chronic health conditions in Lagos, Nigeria. BMC Complement Altern Med (2008) 1.33
Physical and psychosocial benefits of yoga in cancer patients and survivors, a systematic review and meta-analysis of randomized controlled trials. BMC Cancer (2012) 1.32
The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study. BMC Cancer (2006) 1.30
Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med (2007) 1.27
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis (2013) 1.27
Use of complementary/alternative medicine among paediatric patients. Eur J Pediatr (2003) 1.24
Chiropractic and CAM utilization: a descriptive review. Chiropr Osteopat (2007) 1.20
The behaviors of seeking a second opinion from other health-care professionals and the utilization of complementary and alternative medicine in gynecologic cancer patients. Support Care Cancer (2005) 1.19
Mindfulness-based stress reduction for breast cancer-a systematic review and meta-analysis. Curr Oncol (2012) 1.16
Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey. Support Care Cancer (2004) 1.12
Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality. Br J Clin Pharmacol (2003) 1.12
Complementary and alternative medicine for cancer pain: an overview of systematic reviews. Evid Based Complement Alternat Med (2014) 1.05
Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis. J Neurol (2006) 1.03
Use of selected complementary and alternative medicine (CAM) treatments in veterans with cancer or chronic pain: a cross-sectional survey. BMC Complement Altern Med (2006) 1.03
Factors related to the use of dietary supplements by cancer survivors. J Altern Complement Med (2009) 1.01
Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer (2007) 1.01
Physician and patient attitudes towards complementary and alternative medicine in obstetrics and gynecology. BMC Complement Altern Med (2008) 1.01
The value of acupuncture in cancer care. Hematol Oncol Clin North Am (2008) 1.00
Practices, attitudes, and beliefs associated with complementary and alternative medicine (CAM) use among cancer patients. Integr Cancer Ther (2012) 0.99
The use of herbal medicines by people with cancer: a cross-sectional survey. Br J Cancer (2011) 0.99
Investigation on Semecarpus Lehyam--a Siddha medicine for breast cancer. Planta (2004) 0.99
Complementary and alternative medicine: use and disclosure in radiation oncology community practice. Support Care Cancer (2010) 0.98
Integrative oncology for breast cancer patients: introduction of an expert-based model. BMC Cancer (2012) 0.96
Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapy. Support Care Cancer (2007) 0.96
Health food store recommendations: implications for breast cancer patients. Breast Cancer Res (2003) 0.96
The use of Complementary and Alternative Medicine by cancer patients. Int Semin Surg Oncol (2007) 0.95
Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study. BMC Complement Altern Med (2013) 0.95
Use of Chinese medicine by cancer patients: a review of surveys. Chin Med (2011) 0.95
Utilization of and Attitudes towards Traditional Chinese Medicine Therapies in a Chinese Cancer Hospital: A Survey of Patients and Physicians. Evid Based Complement Alternat Med (2012) 0.92
Mapping patterns of complementary and alternative medicine use in cancer: an explorative cross-sectional study of individuals with reported positive "exceptional" experiences. BMC Complement Altern Med (2008) 0.92
Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study. Support Care Cancer (2011) 0.92
Is a biopsychosocial-spiritual approach relevant to cancer treatment? A study of patients and oncology staff members on issues of complementary medicine and spirituality. Support Care Cancer (2005) 0.92
Practitioners' sources of clinical information on complementary and alternative medicine in oncology. Support Care Cancer (2003) 0.91
Aqueous Extract of Solanum nigrum Leaves Induces Autophagy and Enhances Cytotoxicity of Cisplatin, Doxorubicin, Docetaxel, and 5-Fluorouracil in Human Colorectal Carcinoma Cells. Evid Based Complement Alternat Med (2013) 0.91
Use of complementary and alternative medicine by cancer patients at Zhejiang University Teaching Hospital Zhuji Hospital, China. Afr J Tradit Complement Altern Med (2010) 0.91
Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use. Evid Based Complement Alternat Med (2013) 0.91
How oncologists discuss complementary therapy use with their patients: an audio-tape audit. Support Care Cancer (2003) 0.90
Therapeutic applications of herbal medicines for cancer patients. Evid Based Complement Alternat Med (2013) 0.90
Greco-arab and islamic herbal-derived anticancer modalities: from tradition to molecular mechanisms. Evid Based Complement Alternat Med (2011) 0.90
Nutraceutical use in late-stage cancer. Cancer Metastasis Rev (2010) 0.90
Hypnotherapy: fact or fiction: a review in palliative care and opinions of health professionals. Indian J Palliat Care (2011) 0.90
Complementary and alternative medicine in patients with chronic lymphocytic leukemia. Support Care Cancer (2008) 0.89
Treatment delay in oral and oropharyngeal cancer in our population: the role of socio-economic factors and health-seeking behaviour. Indian J Otolaryngol Head Neck Surg (2011) 0.89
Use of complementary and alternative medicine among Korean cancer patients. Korean J Intern Med (2004) 0.89
Aqueous Extract of Solanum nigrum Leaf Activates Autophagic Cell Death and Enhances Docetaxel-Induced Cytotoxicity in Human Endometrial Carcinoma Cells. Evid Based Complement Alternat Med (2012) 0.88
Cancer patients' attitudes towards Chinese medicine: a Hong Kong survey. Chin Med (2009) 0.88
Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients. Evid Based Complement Alternat Med (2011) 0.87
Prayer-for-health and complementary alternative medicine use among Malaysian breast cancer patients during chemotherapy. BMC Complement Altern Med (2014) 0.87
Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in Norway. Support Care Cancer (2004) 0.86
Patient-physician communication about complementary and alternative medicine in a radiation oncology setting. Int J Radiat Oncol Biol Phys (2012) 0.86
Discrepant views of Korean medical oncologists and cancer patients on complementary and alternative medicine. Cancer Res Treat (2008) 0.86
Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway. Support Care Cancer (2008) 0.85
Prospective investigation of complementary and alternative medicine use and subsequent hospitalizations. BMC Complement Altern Med (2008) 0.85
Acupuncture-related rapid dermal spread of breast cancer: a rare case. J Breast Cancer (2011) 0.84
Cancer care experiences and the use of complementary and alternative medicine at end of life in Nova Scotia's Black Communities. J Transcult Nurs (2010) 0.84
Consumer empowerment in dermatology. Dermatol Clin (2009) 0.84
Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD. BMC Complement Altern Med (2012) 0.84
Coprescription of Chinese Herbal Medicine and Western Medications among Prostate Cancer Patients: A Population-Based Study in Taiwan. Evid Based Complement Alternat Med (2011) 0.83
Prevalence of dietary supplement use in patients with proven or suspected cardiovascular disease. Evid Based Complement Alternat Med (2010) 0.83
Perceptions and attitudes of Japanese gynecologic cancer patients to Kampo (Japanese herbal) medicines. Int J Clin Oncol (2011) 0.83
Barriers to biomedical care and use of traditional medicines for treatment of cervical cancer: an exploratory qualitative study in northern Uganda. Eur J Cancer Care (Engl) (2014) 0.83
Complementary and alternative medicine use amongst Malaysian orthopaedic oncology patients. BMC Complement Altern Med (2014) 0.82
Complementary and alternative medicine and coping in neuroimmunological diseases. J Neurol (2007) 0.82
Complementary and alternative medicine in multiple sclerosis. J Neurol (2008) 0.82
Screening to Identify Commonly Used Chinese Herbs That Affect ERBB2 and ESR1 Gene Expression Using the Human Breast Cancer MCF-7 Cell Line. Evid Based Complement Alternat Med (2014) 0.82
Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy -- case report and review of literature. Radiat Oncol (2006) 0.81
Sources and types of online information that breast cancer patients read and discuss with their doctors. Palliat Support Care (2013) 0.81
Corporate culture assessments in integrative oncology: a qualitative case study of two integrative oncology centers. Evid Based Complement Alternat Med (2013) 0.81
Complementary and alternative medicine (CAM) and supportive care in cancer: a synopsis of research perspectives and contributions by an interdisciplinary team. Support Care Cancer (2007) 0.81
Patients in Northwestern Turkey Prefer Herbs as Complementary Medicine after Breast Cancer Diagnosis. Breast Care (Basel) (2008) 0.80
Ethical issues related to patient use of complementary and alternative medicine. J Oncol Pract (2009) 0.80
Biologically based therapies are commonly self-prescribed by Brazilian women for the treatment of advanced breast cancer or its symptoms. Support Care Cancer (2013) 0.80
Complementary and Alternative Medicine: Where do we stand in the 21 century? Sultan Qaboos Univ Med J (2011) 0.80
Quality of Life in CAM and Non-CAM Users among Breast Cancer Patients during Chemotherapy in Malaysia. PLoS One (2015) 0.80
Young women's experiences with complementary therapies during cancer described through illness blogs. West J Nurs Res (2013) 0.80
Efficacy of Compound Kushen Injection in Relieving Cancer-Related Pain: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med (2015) 0.80
Are herbal remedies and dietary supplements safe and effective for breast cancer patients? Breast Cancer Res (2003) 0.80
Complementary therapies in cancer patients: prevalence and patients' motives. Wien Klin Wochenschr (2003) 0.79
Use of complementary medications among older adults with cancer. Cancer (2012) 0.79
Drug-induced liver injury associated with Complementary and Alternative Medicine: a review of adverse event reports in an Asian community from 2009 to 2014. BMC Complement Altern Med (2016) 0.79
Self-reported quality of life in users and nonusers of dietary supplements in cancer. Support Care Cancer (2005) 0.79
Integrating complementary and alternative medicine with primary health care. Evid Based Complement Alternat Med (2013) 0.78
Reiki and related therapies in the dialysis ward: an evidence-based and ethical discussion to debate if these complementary and alternative medicines are welcomed or banned. BMC Nephrol (2013) 0.78
Cancer and complementary medicine: an international perspective. Support Care Cancer (2007) 0.78
Complementary and alternative medicine use by otolaryngology patients: a paradigm for practitioners in all surgical specialties. Eur Arch Otorhinolaryngol (2009) 0.78
Alternative therapy and abnormal liver function during adjuvant chemotherapy in breast cancer patients. J Korean Med Sci (2004) 0.78
Reasons to Use and Disclose Use of Complementary Medicine Use - An Insight from Cancer Patients. Cancer Clin Oncol (2013) 0.78
Perceptions about complementary and alternative medicine use among Chinese immigrant parents of children with cancer. Support Care Cancer (2011) 0.78
Information and participation preferences among cancer patients. Ann Intern Med (1980) 11.05
Informed consent -- why are its goals imperfectly realized? N Engl J Med (1980) 6.43
Harmless herbs? A review of the recent literature. Am J Med (1998) 2.87
Attitudes toward clinical trials among patients and the public. JAMA (1982) 2.53
Psychosocial status in chronic illness. A comparative analysis of six diagnostic groups. N Engl J Med (1984) 2.24
Symptom prevalence and control during cancer patients' last days of life. J Palliat Care (1990) 2.22
Breast cancer surveillance: on increasing its effectiveness while reducing its negative psychological effects. J Natl Cancer Inst (1992) 2.04
Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners. Ann Intern Med (1984) 2.03
The "Hoddle Muddle": using faith healers and other complementary therapists in sports medicine. Br J Sports Med (1998) 2.01
Does use of alternative medicine predict survival from cancer? Eur J Cancer (2003) 1.62
Psychosocial correlates of survival in advanced malignant disease? N Engl J Med (1985) 1.48
Stress and the development of breast cancer: a persistent and popular link despite contrary evidence. Cancer (1996) 1.37
How well do physicians recognize melanoma and other problem lesions? J Am Acad Dermatol (1986) 1.34
Massage therapy for low back pain: a systematic review. J Pain Symptom Manage (1999) 1.33
Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol (1998) 1.31
A psychological analysis of cancer patients and their next-of-kin. Cancer (1985) 1.17
Program evaluation in terminal care. Hosp J (1985) 1.15
Does post-exercise massage treatment reduce delayed onset muscle soreness? A systematic review. Br J Sports Med (1998) 1.12
How useful are unconventional cancer treatments? Eur J Cancer (1999) 1.07
Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in Norway. Eur J Cancer (2004) 1.05
Patients' perceptions of the cosmetic impact of melanoma resection. Plast Reconstr Surg (1983) 1.00
Unconventional therapies for cancer and cancer-related symptoms. Lancet Oncol (2001) 0.99
Relationship between patients' early recognition of melanoma and depth of invasion. Cancer (1982) 0.98
A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol (1988) 0.96
The effect of experience on radiation therapy patients' desire for information. Int J Radiat Oncol Biol Phys (1980) 0.90
A psychological comparison of patients with malignant melanoma and other dermatologic disorders. J Am Acad Dermatol (1982) 0.86
Effect of audiovisual cancer programs on patients and families. J Med Educ (1982) 0.85
Concordance of depression and anxiety in patients with cancer. Psychol Rep (1984) 0.84
Chemotherapeutic toxicity--the relationship between patients' pretreatment expectations and posttreatment results. Am J Clin Oncol (1985) 0.84
The effect of ethnicity on ICU use and DNR orders in hospitalized AIDS patients. J Clin Ethics (1997) 0.83
Acupuncture as an adjuvant therapy in stroke rehabilitation? Wien Med Wochenschr (1996) 0.82
Acupuncture/acupressure for weight reduction? A systematic review. Wien Klin Wochenschr (1997) 0.82
Anxiety levels in patients randomized to adjuvant therapy versus observation for early breast cancer. J Clin Oncol (1986) 0.81
Factors associated with psychological distress in cancer patients. Med Pediatr Oncol (1986) 0.81
Methodologic issues in palliative care psychosocial research. J Palliat Care (1989) 0.77
Sounding boards. After laetrile, what? N Engl J Med (1982) 0.77
Psychological preparation of the patient and family. Cancer (1987) 0.77
Unorthodox cancer medicine. Cancer Invest (1986) 0.76
Thymus therapy for cancer. Eur J Cancer (1997) 0.75
Modification of medical student perceptions of the cancer experience. J Med Educ (1979) 0.75
Hospice and the biopsychosocial model of health care. Am J Hosp Care (1984) 0.75
Psychosocial problems and support of the advanced cancer patient. Rays (1987) 0.75
"Catalyst" symptoms in malignant melanoma. J Gen Intern Med (1987) 0.75
Care of the terminally ill patient and family. Del Med J (1983) 0.75
Physicians heal thyselves! J Altern Complement Med (2001) 0.75
Anxiety levels in patients with malignant disease. Hosp J (1986) 0.75
Score cards for AIDS care. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.75
'Complementary' or 'alternative'? It makes a difference in cancer care. Complement Ther Med (1999) 0.75
Perceptions of oncology as a medical specialty. J Med Educ (1980) 0.75
The evolution of oncology. Perspect Biol Med (1983) 0.75
The use of photographs of postoperative results prior to melanoma resection. Plast Reconstr Surg (1984) 0.75
The care of the patient, revisited. Arch Intern Med (1982) 0.75
Needs and recommendations for behavior research in the prevention and early detection of cancer. Cancer (1991) 0.75
Hospice: the rise and implications of a new addition to the health care scene. Health Law Proj Libr Bull (1980) 0.75